Puma Biotechnology Inc.

PBYI | NASDAQ

Price Alert Chart Builder DCF Calculator

$9.92

+$0.33 (+3.44%)

Sep 22, 2026, 11:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.44%

(1D)

Rating

Updated: Aug 11, 2026

Fundamentals Strong

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $504.95M

1D Range

9.57 9.97

52W Range

4.47 9.98

Valuation (TTM)

PE 18.44

PB 3.52

EV/EBITDA 8.37

Valuation (NTM)

Forward PE 48.18

Forward PEG -0.38

Price Target $6

Cash Flow

FCF Yield 11.6%

SBC Adj. FCF Yield 9.7%

SBC Impact -16.0%

Margins

Gross Margin 74.8%

Operating Margin 13.2%

FCF Margin 24.5%

Growth (CAGR)

Revenue 3Y | 5Y 0.2% | -1.9%

Dil EPS 3Y | 5Y 29.3% | 244.2%

FCF 3Y | 5Y 71.0% | 103.1%

Returns

ROA 13.9%

ROE 20.9%

ROIC 18.2%

Financial Health

Net Cash

$89.08M

Current Ratio 2.91

Interest Coverage 8.65

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administ...

Sector Healthcare

Industry Biotechnology

Employees 179

IPO Date Apr 23, 2012

Website www.pumabiotechnology.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Downside

-39.52%

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞